Venlafaxine
Venlafaxine 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Obesity, Morbid。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
18 项
全球在招研究
6 项
已进入 III/IV 期
15 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Norwegian University of Science and Technology
- Guangdong Provincial People's Hospital
- Assistance Publique - Hôpitaux de Paris
- Beijing Tiantan Hospital
- Duke University
- University of Illinois Chicago
- Mehmet Kemal Arikan
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
中国、法国、美国、加拿大、Turkey (Türkiye)、Israel、奥地利、德国、Greece、意大利、西班牙、英国
正在招募患者的 Venlafaxine 研究
Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
不适用招募中中国NCT07025590Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia
III 期招募中法国NCT07120880The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster
不适用招募中中国NCT07361809Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
不适用招募中美国加拿大NCT03511118Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
II 期招募中美国NCT06591091Neurobiological and Genomic Predictors of Relapse in Depression
不适用招募中Turkey (Türkiye)NCT07328373Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
不适用招募中加拿大NCT05830279Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder
II 期招募中中国NCT07330648Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
III 期招募中IsraelNCT05603104Tracking Response to Antidepressants in Advance of Investigational Trials
不适用招募中美国NCT04748276The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
不适用招募中中国NCT07186751Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
III 期招募中法国NCT06508710The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
不适用招募中中国NCT07361796The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
III 期招募中奥地利德国Greece意大利NCT05973786Bariatric Surgery and Pharmacokinetics of Venlafaxine
不适用招募中挪威NCT03532477REDucing Hot FLASHes in Women Using Endocrine Therapy.
III 期招募中荷兰NCT06106529Pragmatic Trial of Obsessive-compulsive Disorder
II 期招募中中国NCT04539951Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder
IV 期招募中IndiaNCT06803485
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。